Published in Drug Week, May 14th, 2010
"from this study showed no accumulation of radioactivity in any of the tissues studied, indicating that the position of the C-14-label on the molecule was appropriate for the human study. After a single 80-mg (100 mu Ci) oral dose of [1'-C-14] stavudine, approximately 95% of the radioactive dose was excreted in urine with an elimination half-life of 2.35 h. Fecal...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week